Azitra (NYSEAMERICAN:AZTR – Get Free Report) is expected to be releasing its results before the market opens on Tuesday, May 12th. Analysts expect Azitra to post earnings of ($0.01) per share for the quarter.
Azitra Stock Down 6.6%
AZTR stock traded down $0.02 during midday trading on Tuesday, hitting $0.24. The stock had a trading volume of 229,160 shares, compared to its average volume of 9,325,650. Azitra has a 12-month low of $0.10 and a 12-month high of $2.40. The company’s 50-day moving average price is $0.21 and its 200 day moving average price is $0.30.
Azitra Company Profile
Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.
The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.
Recommended Stories
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
